CREO MEDICAL GROUP PLC
Other Manufacturing, Scientific Research, Human Health
Employer Snapshot
Growth-stage company with sound financial footing. Net profit fell from -£21.7m to -£28.7m year-on-year. Operating margin is only -720.0%, which leaves little room for cost pressure. 3 director changes landed in the last 12 months. Limited public workplace data for a company of this size — worth exploring in interviews.
Risks & Warnings(4 found)
Positive Signals(2 found)
Directors
6
3 resigned recently
Accounts
group
Up to date
Last Accounts Made Up
31 December 2024
Next Accounts Due
30 June 2026
Company Age
9yr
Est. 2016
Data Status
A background job is already fetching and normalizing the latest filed accounts so the company page can fill in without blocking the initial load.
Signal Matching
Financial Snapshot
Revenue
Net Loss
Profit Change
Operating Margin
Year ending 2024-12-31
Profit dropped from -£21.7m to -£28.7m year-on-year, a material deterioration in earnings.
Operating profit margin is only -720.0%, which is a thin cushion if costs rise or volumes soften.
Want the full picture?
We analysed 119 data points across 2 official sources for CREO MEDICAL GROUP PLC
- Employer health score & breakdown
- Financial deep-dive with 3-year trends
- All 4 red flags + 2 signals explained
- AI-generated executive summary
- Director timeline & analysis
- Interview questions tailored to this company
- PDF download
One-off payment · Instant access · No account needed
Executive Summary
Expanded viewExpanded executive analysis
Financial Analysis
Expanded view3-year financial trend analysis
Director Timeline & Event History
Expanded viewAppointment history and enforcement records
This report is based on publicly available data and algorithmic analysis. It is not financial, legal, or credit advice.
Sources: Companies House, GOV.UK Gender Pay Gap Service, Living Wage Foundation, HSE, Employment Tribunals, FCA, CQC, Trustpilot, Google News.